Fung, S. Et Al. 2017. Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study. JOURNAL OF HEPATOLOGY , vol.66, no.1 , 11-18.

Fung, S., Kwan, P., Fabri, M., Horban, A., Pelemis, M., Hann, H., ... GÜREL, S.(2017). Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study. JOURNAL OF HEPATOLOGY , vol.66, no.1, 11-18.

Fung, Scott Et Al. "Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study," JOURNAL OF HEPATOLOGY , vol.66, no.1, 11-18, 2017

Fung, Scott Et Al. "Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study." JOURNAL OF HEPATOLOGY , vol.66, no.1, pp.11-18, 2017

Fung, S. Et Al. (2017) . "Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study." JOURNAL OF HEPATOLOGY , vol.66, no.1, pp.11-18.

@article{article, author={Scott Fung Et Al. }, title={Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study}, journal={JOURNAL OF HEPATOLOGY}, year=2017, pages={11-18} }